Loading clinical trials...
Loading clinical trials...
A Phase Ⅰ/Ⅱ, Multicenter, Single-arm, Open-label Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations
Conditions
Interventions
EHT102 Injection
Locations
1
China
Eye & ENT Hospital of Fudan University
Shanghai, Shanghai Municipality, China
Start Date
April 2, 2026
Primary Completion Date
June 30, 2028
Completion Date
December 30, 2033
Last Updated
April 14, 2026
Lead Sponsor
Shanghai Euhearing Therapeutics Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions